Press release
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies 2016 | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update" to its huge collection of research reports.This Competitive Intelligence report about Biosimilar & Biosuperior Therapeutic Antibodies updates the competitive landscape of biosimilar therapeutic antibodies as of May 2016. The report evaluates the the first wave of biosimilar recombinant monoclonal antibodies in comparison with the corresponding originator antibodies and biosuperior antibodies against the same target. The report also describes the next wave of potential biosimilar versions of therapeutic antibodies loosing patent protection in the time frame of 2019 – 2023. The report specifically lists for each target the branded products with their 2015 sales and up-side indications in development, as well as biosuperior and biosimilar antibody drug candidates in development.
The report includes a compilation of marketed, approved and currently active projects in research and development of biosimilar and biosuperior therapeutic antibodies against commercially and clinically validated targets relevant for the first wave of biosimilar antibodies (VEGF, TNF, Her2, CD20, EGF-R). Relevant first wave originator therapeutic antibodies are Humira, Enbrel, Remicade, Avastin, Lucentis, Eylea, Herceptin, Rituxan/MabThera and Erbitux. Second generation therapeutic antibodies against these targets such as Symponi, Cimzia, Cyramza, Perjeta, Arrzera are also subject of biosimilar activities.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=724046
The report also addresses the slowly emerging second wave of biosimilar antibody activities against originator therapeutic antibodies such as abatacept, alemtuzumab, denosumab, eculizumab, omalizumab, pavilizumab, tocilizumab, and ustekinumab.
Competitor projects are listed in a tabular format providing information on:
- Drug Codes,
- Target/Mechanism of Action,
- Class of Compound,
- Company,
- Product Category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=724046
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies 2016 | Now Available at Researchmoz.us here
News-ID: 393566 • Views: …
More Releases from Biosimilar & Biosuperior Therapeutic Antibodies
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Upda …
MarketResearchReports.Biz presents this most up-to-date research on "Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update"
This Competitive Intelligence report about Biosimilar & Biosuperior Therapeutic Antibodies updates the competitive landscape of biosimilar therapeutic antibodies as of May 2016. The report evaluates the the first wave of biosimilar recombinant monoclonal antibodies in comparison with the corresponding originator antibodies and biosuperior antibodies against the same target. The report also describes the next…
More Releases for Competitor
Agrochemicals Market 2030 Competitor Analysis
The Agrochemicals Market is expected to register a CAGR of 4% from 2024 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
Access PDF: https://www.theinsightpartners.com/sample/TIPRE00003559/?utm_source=OpenPR&utm_medium=10864
Product type: Fertilizers, Pesticides & Plant growth regulators.
Crop Type: Cereals and Grains; Fruits and Vegetables; Oilseeds and Pulses.
Application Method: Foliar Spray, Soil Treatment & Seed Treatment.
A few players operating in the global agrochemicals market include…
Plant Growth Regulators Market Growth & Competitor Segment Analysis, With Busine …
Plant Growth Regulators Market is expected to rise from its initial estimated value of USD 5.32 billion in 2018 to an estimated value of USD 9.15 billion by 2026 registering a CAGR of 7.0% in the forecast period of 2019-2026. This rise in the market can be attributed to the growing awareness towards the green technology and high demand of the organic foods.
FREE | Sample Copy Of Report@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-plant-growth-regulators-market
Key…
2018 Banking Competitor Profile: Barclays
Barclays is one of the largest banks in the UK, and is a leading provider of all the main banking products. Mortgages are a particular strength for the bank - it has won a number of awards for its product range and has an NPS score three times higher than the market average. Barclays customers are heavy users of mobile banking - a quarter use this channel on a daily…
Banking Competitor Profile: Santander
Santander is a leading UK provider, and has achieved notable success in recent years with its 123 Current Account, which has attracted substantial numbers of new customers. It also recently acquired a specialist provider of motor finance, which has boosted its market share in lending. Although Santander’s costs relative to income are in line with those of other banks, price competition has hit its net interest margins, and consequently its…
Banking Competitor Profile: Santander
Santander is a leading UK provider, and has achieved notable success in recent years with its 123 Current Account, which has attracted substantial numbers of new customers. It also recently acquired a specialist provider of motor finance, which has boosted its market share in lending. Although Santander’s costs relative to income are in line with those of other banks, price competition has hit its net interest margins, and consequently its…
Insurance Competitor Profile: Aviva 2016
MarketResearchReports.Biz presents this most up-to-date research on "Insurance Competitor Profile: Aviva 2016"
Description
This profile offers a review of Aviva, its business structure and strategy, its financial performance, and a SWOT analysis.
Aviva has 34 million customers worldwide and 16 million in the UK (before the deduction of Friends Life Groups overlapping customers). Aviva has a presence in 16 countries. Outside of the UK, it has a strong presence in Canada, France, Ireland,…
